Whole Bowel Irrigation in Toxicology: Indications
Whole bowel irrigation (WBI) should be considered for three specific toxicologic scenarios: sustained-release or enteric-coated drug ingestions (particularly >2 hours post-ingestion), substantial ingestions of iron/lithium/potassium, and body packers with drug packets, though it should not be used routinely due to lack of outcome data. 1, 2
Primary Indications
Sustained-Release and Enteric-Coated Preparations
- WBI is indicated for potentially toxic ingestions of sustained-release or enteric-coated drugs, especially when patients present more than 2 hours after ingestion when activated charcoal becomes less effective 1, 2
- Volunteer studies demonstrate substantial decreases in drug bioavailability with this approach, though clinical outcome data remain limited 1, 3
Metals and Electrolytes Not Adsorbed by Charcoal
- WBI should be considered for substantial ingestions of iron, as morbidity is high and alternative gastrointestinal decontamination options are lacking 1, 2
- Lithium and potassium ingestions also warrant consideration for WBI given these substances are not effectively bound by activated charcoal 1
Body Packers
- WBI is indicated for removal of ingested packets of illicit drugs in "body packers" 1, 2
- This represents a unique scenario where mechanical removal of intact drug packets is the therapeutic goal 3
Critical Limitations and Contraindications
Absolute Contraindications
- Bowel obstruction, perforation, or ileus 1, 2
- Hemodynamic instability 1, 2
- Compromised or unprotected airways 1, 2
Relative Contraindications and Cautions
- Use cautiously in debilitated patients 1, 2
- Exercise caution in patients with medical conditions that might be further compromised by WBI 1, 2
Important Clinical Considerations
Interaction with Activated Charcoal
- Concurrent administration of activated charcoal and WBI may decrease charcoal effectiveness, though the clinical relevance remains uncertain 1, 2
- If both are needed, timing and sequencing should be carefully considered 3
Evidence Quality Warning
- No controlled clinical trials demonstrate that WBI improves patient outcomes in poisoning cases 4, 1, 2
- Recommendations are based primarily on volunteer studies showing decreased drug bioavailability and observational data confirming tablet/packet expulsion 4, 1
- The procedure is challenging for inexperienced physicians and carries risk of adverse effects 4
Administration Details
- Typical administration involves large volumes of polyethylene glycol-electrolyte solution (mean ~7.7 L over ~234 minutes in studies) 5
- The goal is complete gastrointestinal tract emptying before systemic toxin absorption 4
When NOT to Use WBI
WBI should not be used routinely in poisoned patients 4, 1, 2. The lack of robust prospective evidence demonstrating efficacy, combined with administration challenges and potential adverse effects, limits its use to the specific scenarios outlined above 4.